Revisiting Type 2‐high and Type 2‐low airway inflammation in asthma: current knowledge and therapeutic implications
Top Cited Papers
Open Access
- 30 January 2017
- journal article
- review article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 47 (2), 161-175
- https://doi.org/10.1111/cea.12880
Abstract
Asthma is a complex respiratory disorder characterized by marked heterogeneity in individual patient disease triggers and response to therapy. Several asthma phenotypes have now been identified, each defined by a unique interaction between genetic and environmental factors, including inflammatory, clinical and trigger-related phenotypes. Endotypes further describe the functional or pathophysiologic mechanisms underlying the patient's disease. type 2-driven asthma is an emerging nomenclature for a common subtype of asthma and is characterized by the release of signature cytokines IL-4, IL-5 and IL-13 from cells of both the innate and adaptive immune systems. A number of well-recognized biomarkers have been linked to mechanisms involved in type 2 airway inflammation, including fractional exhaled nitric oxide, serum IgE, periostin, and blood and sputum eosinophils. These type 2 cytokines are targets for pharmaceutical intervention, and a number of therapeutic options are under clinical investigation for the management of patients with uncontrolled severe asthma. Anticipating and understanding the heterogeneity of asthma and subsequent improved characterization of different phenotypes and endotypes must guide the selection of treatment to meet individual patients’ needs.Keywords
Funding Information
- AstraZeneca
- Chiesi Farmaceutici
- Roche
- Teva Pharmaceutical Industries
- Boehringer Ingelheim
- GlaxoSmithKline
- Novartis
- Merck Sharp and Dohme
- Astellas Pharma US
- Pfizer
- Sanofi
This publication has 168 references indexed in Scilit:
- Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroidsJournal of Allergy and Clinical Immunology, 2013
- The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4+ T cellsNature Immunology, 2011
- Metabolomic profiling of asthma: Diagnostic utility of urine nuclear magnetic resonance spectroscopyJournal of Allergy and Clinical Immunology, 2011
- Roles of epithelial cell-derived periostin in TGF-β activation, collagen production, and collagen gel elasticity in asthmaProceedings of the National Academy of Sciences, 2010
- In vivo studies fail to reveal a role for IL-4 or STAT6 signaling in Th2 lymphocyte differentiationProceedings of the National Academy of Sciences, 2008
- The course of persistent airflow limitation in subjects with and without asthmaRespiratory Medicine, 2008
- Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responsesMucosal Immunology, 2008
- Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor α1 chainNature Immunology, 2007
- Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroidsProceedings of the National Academy of Sciences, 2007
- Unique Maturation Program of the IgE Response In VivoImmunity, 2007